share_log

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF) Short Interest Down 43.5% in February

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF) Short Interest Down 43.5% in February

TAAT Global Alternatives Inc.(OTCMKTS: TOBAF)2月份空頭利率下降了43.5%
Financial News Live ·  2023/03/02 08:03

TAAT Global Alternatives Inc. (OTCMKTS:TOBAF – Get Rating) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 256,900 shares, a drop of 43.5% from the January 31st total of 455,000 shares. Based on an average daily trading volume, of 47,100 shares, the days-to-cover ratio is presently 5.5 days.

TAAT Global Alternatives Inc.(OTCMKTS: TOBAF — 獲取評級)是2月份空頭利息大幅下降的接受者。截至2月15日,空頭利息總額爲25.69萬股,較1月31日的45.5萬股下降了43.5%。根據47,100股的平均每日交易量,目前的回報天數比率爲5.5天。

TAAT Global Alternatives Stock Performance

TAAT 全球另類股票表現

Shares of TAAT Global Alternatives stock opened at $0.33 on Thursday. TAAT Global Alternatives has a one year low of $0.22 and a one year high of $1.50. The company has a debt-to-equity ratio of 0.26, a quick ratio of 2.39 and a current ratio of 3.69. The company has a market cap of $35.33 million, a price-to-earnings ratio of -1.62 and a beta of 1.09. The business's 50 day moving average price is $0.34 and its 200 day moving average price is $0.50.

TAAT Global Alternatives股票週四開盤價爲0.33美元。TAAT Global Alternatives的一年低點爲0.22美元,一年來的最高點爲1.50美元。該公司的債務與權益比率爲0.26,速動比率爲2.39,流動比率爲3.69。該公司的市值爲3533萬美元,市盈率爲-1.62,beta值爲1.09。該公司的50天移動平均價格爲0.34美元,其200天移動平均線價格爲0.50美元。

Get
獲取
TAAT Global Alternatives
TAAT 全球替代品
alerts:
警報:

TAAT Global Alternatives Company Profile

TAAT 全球另類投資公司簡介

(Get Rating)

(獲取評分)

TAAT Global Alternatives Inc is an early-stage life sciences company. It focuses on hemp and the association with health and fitness. Its product portfolio includes Hemp cigarettes. The company was founded on June 5, 2006 and is headquartered in Vancouver, Canada.

TAAT Global Alternatives Inc是一家早期生命科學公司。它側重於大麻及其與健康和健身的關係。其產品組合包括大麻香菸。該公司成立於2006年6月5日,總部位於加拿大溫哥華。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on TAAT Global Alternatives (TOBAF)
  • Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor
  • Has Workhorse Group Finally Hit Bottom?
  • Target Offering A Rare Buying Opportunity After Earnings
  • Rivian Gives Investors a Taste of the Anxiety Its Consumers Feel
  • 3 High-Yield Dividend Stocks That Are Probably Not On Your Radar
  • 免費獲取 StockNews.com 關於 TAAT 全球替代方案 (TOBAF) 的研究報告的副本
  • 華爾街認爲肉毒桿菌毒素競爭對手Revance有23%的上漲空間
  • Workhorse 集團終於觸底了嗎?
  • Target 在盈利後提供難得的買入機會
  • Rivian 讓投資者體會到其消費者所感受到的焦慮
  • 3 只可能不在你的關注範圍內的高收益股息股票

Receive News & Ratings for TAAT Global Alternatives Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TAAT Global Alternatives and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收TAAT全球另類投資的新聞和收視率 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊接收TAAT Global Alternates和相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論